IBOImpact BioMedical Inc.
0.5351USD+3.68%Mkt Cap: 57.70M USDP/E: Last update: 2026-06-01

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer heal…

Indicators:|

Key Statistics

Company
Market Cap57.70M USD
Enterprise Value59.29M USD
Revenue (TTM)39.00K USD
Gross Profit-392.00K USD
Net Income (TTM)-11.84M USD
Revenue/Share0.0010 USD
Last Price0.5351 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA-13.47
EV/Revenue1520.36
P/S1437.62
P/B4.91
EPS (TTM)-0.29
EPS (Forward)
52W Range
0.362011% of range1.950
52W High1.950 USD
52W Low0.3620 USD
Profitability
Gross Margin-1225.00%
Oper. Margin-32700.00%
EBITDA Margin0.00%
Profit Margin-36993.75%
ROE-93.89%
ROA-68.01%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-1.89M USD
CapEx (TTM)
FCF Margin-2772.76%
FCF Yield-1.87%
Net Debt-20.00K USD
Net Debt/EBITDA0.00
Balance Sheet
Debt/Equity
Current Ratio0.22
Quick Ratio0.01
Book Value/Sh0.1060 USD
Cash/Share0.0000 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.107.82M
Float11.44M
Insiders89.02%
Institutions3.45%
Short Interest
Short Ratio10.5d
Short % Float6.67%
Short % Out.0.73%
Shares Short783.89K
Short (prev mo.)1.21M
Technical
SMA 500.6160 (-13.1%)
SMA 2000.5553 (-3.6%)
Beta
S&P 52W Chg27.94%
Avg Vol (30d)60.05K
Avg Vol (10d)40.18K
Technical Indicators
RSI (14)36.1
MACD-0.0328
MACD Signal-0.0257
MACD Hist.-0.0071
BB Upper0.6826 USD
BB Middle0.5734 USD
BB Lower0.4643 USD
BB Width38.08%
ATR (14)0.0421 USD
Vol Ratio (20d)0.51x